Jacob A. Sloane

3.6k total citations
72 papers, 2.7k citations indexed

About

Jacob A. Sloane is a scholar working on Pathology and Forensic Medicine, Oncology and Neurology. According to data from OpenAlex, Jacob A. Sloane has authored 72 papers receiving a total of 2.7k indexed citations (citations by other indexed papers that have themselves been cited), including 45 papers in Pathology and Forensic Medicine, 15 papers in Oncology and 13 papers in Neurology. Recurrent topics in Jacob A. Sloane's work include Multiple Sclerosis Research Studies (44 papers), Polyomavirus and related diseases (12 papers) and Peripheral Neuropathies and Disorders (10 papers). Jacob A. Sloane is often cited by papers focused on Multiple Sclerosis Research Studies (44 papers), Polyomavirus and related diseases (12 papers) and Peripheral Neuropathies and Disorders (10 papers). Jacob A. Sloane collaborates with scholars based in United States, Sweden and Canada. Jacob A. Sloane's co-authors include Timothy Vartanian, Carmela R. Abraham, Caterina Mainero, Douglas L. Rosene, William Hollander, Mark B. Moss, Céline Louapre, Revere P. Kinkel, Z.M. Harris and Béla Kosaras and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Neuroscience.

In The Last Decade

Jacob A. Sloane

67 papers receiving 2.6k citations

Peers

Jacob A. Sloane

PFM

NEURO

IMMUN

Arnon Karni Israel

Elisabetta Capello Italy

Isabella Wimmer Austria

Refik Pul Germany

Paul Polak United States

Kenneth S. Shindler United States

Istvan Pirko United States

Stefan Nessler Germany

Shalina S. Ousman Canada

Lucas Schirmer Germany

Arnon Karni Israel

Jacob A. Sloane

846 ×1.0

PFM

494 ×0.7

NEURO

449 ×0.7

723 ×1.4

IMMUN

236 ×0.6

Citations per year, relative to Jacob A. Sloane Jacob A. Sloane (= 1×) peers Arnon Karni

Countries citing papers authored by Jacob A. Sloane

Since Specialization

Citations

This map shows the geographic impact of Jacob A. Sloane's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jacob A. Sloane with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jacob A. Sloane more than expected).

Fields of papers citing papers by Jacob A. Sloane

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jacob A. Sloane. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jacob A. Sloane. The network helps show where Jacob A. Sloane may publish in the future.

Co-authorship network of co-authors of Jacob A. Sloane

This figure shows the co-authorship network connecting the top 25 collaborators of Jacob A. Sloane. A scholar is included among the top collaborators of Jacob A. Sloane based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jacob A. Sloane. Jacob A. Sloane is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Conti, Allegra, Constantina A. Treaba, Valeria Barletta, et al.. (2025). Choroid Plexus Enlargement in Multiple Sclerosis Correlates with Cortical and Phase Rim Lesions on 7T MRI and Predicts Progression Independent of Relapse Activity. American Journal of Neuroradiology. 47(2). 557–565.

Sloane, Jacob A., et al.. (2025). Herpes Zoster Infections With Multiple Sclerosis Disease-Modifying Therapies. Neurology Clinical Practice. 15(2). e200462–e200462. 1 indexed citations

Sloane, Jacob A., et al.. (2025). A disproportionality analysis of surgical site infections across multiple sclerosis disease modifying therapies. Journal of Neurology. 272(3). 223–223.

Herranz, Elena, Constantina A. Treaba, Valeria Barletta, et al.. (2024). Characterization of cortico-meningeal translocator protein expression in multiple sclerosis. Brain. 147(7). 2566–2578. 10 indexed citations

Treaba, Constantina A., et al.. (2024). White matter paramagnetic rim and non-rim lesions share a periventricular gradient in multiple sclerosis: A 7-T imaging study. Multiple Sclerosis Journal. 30(2). 166–176. 4 indexed citations

Treaba, Constantina A., Elena Herranz, Valeria Barletta, et al.. (2024). Phenotyping in vivo chronic inflammation in multiple sclerosis by combined ¹¹C-PBR28 MR-PET and 7T susceptibility-weighted imaging. Multiple Sclerosis Journal. 30(14). 1755–1764. 3 indexed citations

Wu, Lisa Y., et al.. (2024). Worsening of lymphopenia in patients with multiple sclerosis when switched from dimethyl fumarate to diroximel fumarate. Multiple Sclerosis and Related Disorders. 89. 105737–105737. 3 indexed citations

AbdelRazek, Mahmoud A., et al.. (2022). Extended B-cell depletion beyond 6-months in patients receiving ocrelizumab or rituximab for CNS demyelinating disease. Multiple Sclerosis and Related Disorders. 59. 103505–103505. 5 indexed citations

Treaba, Constantina A., Allegra Conti, Eric C. Klawiter, et al.. (2021). Cortical and phase rim lesions on 7 T MRI as markers of multiple sclerosis disease progression. Brain Communications. 3(3). fcab134–fcab134. 38 indexed citations

10.

Miravalle, Augusto, Joshua Katz, Derrick Robertson, et al.. (2021). CLICK-MS and MASTER-2 Phase IV Trial Design: Cladribine Tablets in Suboptimally Controlled Relapsing Multiple Sclerosis. Neurodegenerative Disease Management. 11(2). 99–111. 6 indexed citations

11.

Treaba, Constantina A., Valeria Barletta, Elena Herranz, et al.. (2020). Characterization of thalamic lesions and their correlates in multiple sclerosis by ultra-high-field MRI. Multiple Sclerosis Journal. 27(5). 674–683. 18 indexed citations

12.

Ouellette, Russell, Constantina A. Treaba, Tobias Granberg, et al.. (2020). 7 T imaging reveals a gradient in spinal cord lesion distribution in multiple sclerosis. Brain. 143(10). 2973–2987. 25 indexed citations

13.

Treaba, Constantina A., Tobias Granberg, Maria Pia Sormani, et al.. (2019). Longitudinal Characterization of Cortical Lesion Development and Evolution in Multiple Sclerosis with 7.0-T MRI. Radiology. 291(3). 740–749. 62 indexed citations

14.

Koralnik, Igor J., et al.. (2019). Risk factors for lymphopenia in patients with relapsing–remitting multiple sclerosis treated with dimethyl fumarate. Journal of Neurology. 267(1). 125–131. 32 indexed citations

15.

Sloane, Jacob A., J. Theodore Phillips, Jonathan Calkwood, et al.. (2018). Delayed-release Dimethyl Fumarate Demonstrated No Difference in Clinical Outcomes Versus Fingolimod in Patients with Relapsing-Remitting Multiple Sclerosis: Results from the Real-World EFFECT Study (P1.362). Neurology. 90(15_supplement). 2 indexed citations

16.

Sloane, Jacob A., et al.. (2017). PML-IRIS in an HIV-2-infected patient presenting as Bell’s palsy. Journal of NeuroVirology. 23(5). 789–792. 4 indexed citations

17.

Zurawski, Jonathan, et al.. (2016). Relapse frequency in transitioning from natalizumab to dimethyl fumarate: assessment of risk factors. Journal of Neurology. 263(8). 1511–1517. 12 indexed citations

18.

Louapre, Céline, Sindhuja Tirumalai Govindarajan, Costanza Giannì, et al.. (2015). Is the Relationship between Cortical and White Matter Pathologic Changes in Multiple Sclerosis Spatially Specific? A Multimodal 7-T and 3-T MR Imaging Study with Surface and Tract-based Analysis. Radiology. 278(2). 524–535. 11 indexed citations

19.

Hanafy, Khalid A. & Jacob A. Sloane. (2011). Regulation of remyelination in multiple sclerosis. FEBS Letters. 585(23). 3821–3828. 66 indexed citations

20.

Sloane, Jacob A., et al.. (2002). Age‐dependent myelin degeneration and proteolysis of oligodendrocyte proteins is associated with the activation of calpain‐1 in the rhesus monkey. Journal of Neurochemistry. 84(1). 157–168. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact